224 related articles for article (PubMed ID: 15008466)
21. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
[TBL] [Abstract][Full Text] [Related]
22. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
[TBL] [Abstract][Full Text] [Related]
23. Management of the cancer patient with infection and neutropenia.
Rapoport BL
Semin Oncol; 2011 Jun; 38(3):424-30. PubMed ID: 21600373
[TBL] [Abstract][Full Text] [Related]
24. Prophylaxis and treatment of bacterial infections: do we need new strategies?
Micozzi A; Bucaneve G
Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
[TBL] [Abstract][Full Text] [Related]
25. Antibiotics for the prevention of febrile neutropenia.
Pascoe J; Steven N
Curr Opin Hematol; 2009 Jan; 16(1):48-52. PubMed ID: 19057204
[TBL] [Abstract][Full Text] [Related]
26. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
27. Fever and neutropenia in pediatric patients with cancer.
Meckler G; Lindemulder S
Emerg Med Clin North Am; 2009 Aug; 27(3):525-44. PubMed ID: 19646652
[TBL] [Abstract][Full Text] [Related]
28. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
[TBL] [Abstract][Full Text] [Related]
29. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
30. Controversies in the management of fever in the neutropenic cancer patient.
Seftel MD
Transfus Apher Sci; 2010 Apr; 42(2):151-6. PubMed ID: 20106722
[TBL] [Abstract][Full Text] [Related]
31. [Febrile neutropenia at the emergency department of a cancer hospital].
Debey C; Meert AP; Berghmans T; Thomas JM; Sculier JP
Rev Med Brux; 2011; 32(2):74-82. PubMed ID: 21688591
[TBL] [Abstract][Full Text] [Related]
32. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
Chamilos G; Bamias A; Efstathiou E; Zorzou PM; Kastritis E; Kostis E; Papadimitriou C; Dimopoulos MA
Cancer; 2005 Jun; 103(12):2629-35. PubMed ID: 15856427
[TBL] [Abstract][Full Text] [Related]
33. [The infectious complications of bronchial cancer].
Klastersky J
Rev Mal Respir; 1998 Sep; 15(4):451-9. PubMed ID: 9805755
[TBL] [Abstract][Full Text] [Related]
34. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
35. The outpatient management of febrile neutropenia in cancer patients.
Freifeld AG; Pizzo PA
Oncology (Williston Park); 1996 Apr; 10(4):599-606, 611-2; discussion 615-6. PubMed ID: 8723296
[TBL] [Abstract][Full Text] [Related]
36. [Consensus on management of children with cancer, neutropenia and fever: Update 2008-2009].
Comité Nacional de Infectología Pediátrica
Arch Argent Pediatr; 2010 Apr; 108(2):e47-70. PubMed ID: 20467701
[TBL] [Abstract][Full Text] [Related]
37. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
Sung L; Feldman BM; Schwamborn G; Paczesny D; Cochrane A; Greenberg ML; Maloney AM; Hendershot EI; Naqvi A; Barrera M; Llewellyn-Thomas HA
J Clin Oncol; 2004 Oct; 22(19):3922-9. PubMed ID: 15459214
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic Selection in the Treatment of Febrile Neutropenia: Current Approach and New Directions.
Stefani SD; Cadore LP; Villaroel RU; Azevedo S; Machado AL
Braz J Infect Dis; 1998 Jun; 2(3):109-117. PubMed ID: 11102998
[TBL] [Abstract][Full Text] [Related]
39. CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.
Borg C; Ray-Coquard I; Philip I; Clapisson G; Bendriss-Vermare N; Menetrier-Caux C; Sebban C; Biron P; Blay JY
Cancer; 2004 Dec; 101(11):2675-80. PubMed ID: 15503313
[TBL] [Abstract][Full Text] [Related]
40. Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors.
Minisini A; Spazzapan S; Crivellari D; Aapro M; Biganzoli L
Crit Rev Oncol Hematol; 2005 Feb; 53(2):125-31. PubMed ID: 15661563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
